Skip to main content

Table 6 Distribution of dystrophin gene mutation types in the study population

From: Left ventricular systolic function and the pattern of late-gadolinium-enhancement independently and additively predict adverse cardiac events in muscular dystrophy patients

Dystrophin gene mutation type

Total (N = 81)

DMD (N = 20)

BMD (N = 61)

p-value

Deletions affecting the amino-terminal domain, n (%)

11 (14)

1 (5)

10 (16)

0.28

Deletions affecting exons 45–49, n (%)

30 (37)

1 (5)

29 (48)

<0.001

Deletions affecting exons 50 and/or 51, n (%)

15 (19)

8 (40)

7 (12)

0.008

Duplication, n (%)

11 (14)

4 (20)

7 (12)

0.45

Point mutation, n (%)

4 (5)

2 (10)

2 (3)

0.25

Other, n (%)

10 (12)

4 (20)

6 (10)

0.25

  1. DMD – Duchene muscular dystrophy; BMD – Becker muscular dystrophy. Bold numbers indicate significant p-values/parameters.